Asia Pacific Blood Glucose Monitoring Devices Market

The report "Asia Pacific Blood Glucose Monitoring Devices Market by Product Type (Self-blood glucose monitoring, Professional point of care), Application (Diabetes management, Health & wellness Monitoring), Test Site (Fingertip, Upper arm), End User (Self/Homecare) - Forecast to 2030" is projected to grow from USD 3.45 billion in 2025 and to reach USD 5.86 billion in 2030, at a Compound Annual Growth Rate (CAGR) of 11.2% during the forecast period.

Browse 180 market data Tables and 40 Figures spread through 280 Pages and in-depth TOC on "Asia Pacific Blood Glucose Monitoring Devices Market by Product Type (Self-blood glucose monitoring, Professional point of care), Application (Diabetes management, Health & wellness Monitoring), Test Site (Fingertip, Upper arm), End User (Self/Homecare) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-blood-glucose-monitoring-devices-market-137052821.html

Industry development in the Asia Pacific blood glucose monitoring devices market is closely aligned with national healthcare priorities aimed at improving diabetes detection, long-term disease management, and cost containment. The demand is mainly the result of the increasing number of diabetic patients, the growing focus on early diagnosis and regular monitoring, and the greater use of home and home-based and outpatient-based care. The accelerated aging of the population in countries like Japan, China, and South Korea additionally substantiates the requirement of frequent and reliable glucose monitoring. Nevertheless, market adoption is not equal across the region as there are significant differences in reimbursement coverage, pricing controls, and public procurement frameworks that can all limit the uptake of newer and more expensive blood glucose monitoring technologies.

Based on product type, the self-monitoring blood glucose systems segment accounted for the largest share in the Asia Pacific blood glucose monitoring devices market in 2024.

By product type, the Asia Pacific market for blood glucose monitoring devices is divided into self-monitoring blood glucose (SMBG) systems, continuous glucose monitoring (CGM) systems, professional point-of-care systems, and non-invasive systems. SMBG systems accounted for the largest share of the market in 2024, primarily due to their affordability, widespread availability, and strong adoption across large diabetic populations in countries such as China, India, Japan, and Southeast Asia. SMBG devices are extensively used among patients with Type 2 diabetes, particularly those in early disease stages and those managed through lifestyle modification and oral antidiabetic therapies. The dominance of SMBG systems in the region is supported by limited reimbursement coverage for CGM in several APAC countries, high out-of-pocket healthcare expenditure, and the strong presence of retail pharmacy networks, hospital pharmacies, and online channels. In addition, the availability of locally manufactured meters, cost-competitive test strips, and continuous improvements in device accuracy, testing speed, and mobile-based data tracking have sustained the relevance of SMBG systems for routine glucose monitoring across the Asia Pacific region.

Based on application, the diabetes management segment is expected to grow at the highest CAGR during the forecast period.

Based on application, the Asia Pacific blood glucose monitoring devices market is segmented into diabetes management, health and wellness monitoring, and other applications, with diabetes management expected to register the highest growth rate during the forecast period. Most of the growth in this segment is attributed to the increasing number of diabetes patients in major countries like China, India, and countries in Southeast Asia, as well as the growing focus on early diagnosis and long-term glycemic control in both public and private healthcare systems. A good number of Asia Pacific countries are intensifying their national diabetes programs and clinical guidelines, which are therefore encouraging routine blood glucose monitoring to be an integral part of standard diabetes care. The increasing use of continuous glucose monitoring (CGM), especially by insulin-dependent and high-risk patients in developed markets like Japan, South Korea, Australia, and China, is also helping the segment's growth. Besides that, physician awareness, improving patient education initiatives, and making self-monitoring devices for home use more widely available through hospitals, retail pharmacies, and e-commerce channels are collectively contributing to the faster adoption of blood glucose monitoring solutions for diabetes management in the Asia Pacific market.

China is expected to expand with the highest CAGR in the Asia Pacific blood glucose monitoring devices market during the forecast period.

The Asia Pacific blood glucose monitoring devices market is segmented into China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. China is expected to register the highest CAGR, driven by its exceptionally large and aging diabetic population. As per the IDF Diabetes Atlas, 11th Edition (2025), China accounted for 148.0 million adults aged 20–79 years with diabetes in 2024, with this number projected to increase to 168.3 million by 2050, representing the largest patient pool globally. In parallel, China also leads the region in the elderly diabetic population, with 47.9 million people aged over 65 years living with diabetes in 2024, expected to rise significantly to 76.6 million by 2050. This expanding and aging patient base, coupled with improving access to diagnostics, growing awareness of glycemic control, and increasing penetration of self-monitoring and continuous glucose monitoring devices, is accelerating device adoption and positioning China as the primary growth driver within the Asia Pacific blood glucose monitoring devices market.

Key Players

Prominent players in the Asia Pacific blood glucose monitoring devices market include Abbott Laboratories (US), Dexcom, Inc. (US), Medtronic (Ireland), Sinocare (China), B. Braun SE (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Arkray (Japan), i-SENS, Inc. (South Korea), Senseonics (US),  Ascensia Diabetes Care Holdings AG (Switzerland), Nipro (Japan), Medical Technology and Devices S.p.A. (Italy), Terumo Corporation (Japan), SD Biosensor, inc. (South Korea), LifeScan IP Holdings, LLC (US), and A. Menarini Diagnostics S.r.l (Italy).

Don’t miss out on business opportunities in Asia Pacific Blood Glucose Monitoring Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/